Health
Remyelinating drug shows potential to improve vision in patients with MS – News-Medical.Net
A team led by a biomedical scientist at the University of California, Riverside, reports a drug — an estrogen receptor ligand called indazole chloride (IndCl)…
A team led by a biomedical scientist at the University of California, Riverside, reports a drug — an estrogen receptor ligand called indazole chloride (IndCl) — has the potential to improve vision in patients with multiple sclerosis, or MS.
The study, performed on mice induced with a model of MS and the first to investigate IndCl’s effect on the pathology and function of the complete afferent visual pathway, is published in Brain Pathology. The afferent visual pathway includes the eyes, optic…
-
Noosa News22 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Noosa News23 hours agoForum responds to urgent homelessness issues in Nambour
-
Business20 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General16 hours agoMigrants raise concerns over Australia’s English tests for visa applicants